Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury
Inferior Vena Cava Collapsibility Index in Patients With Acute Kidney Injury
1 other identifier
observational
30
1 country
1
Brief Summary
This is an observational study that will examine the possibility of determining the type of Acute Kidney Injury (AKI) using bedside ultrasound machines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 13, 2014
CompletedFirst Posted
Study publicly available on registry
June 17, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedResults Posted
Study results publicly available
June 23, 2016
CompletedJune 23, 2016
June 1, 2016
1.7 years
June 13, 2014
November 2, 2015
June 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Maximum and Minimum Diameters of the Inferior Vena Cava in Patients With Acute Kidney Injury
The investigators will measure the maximum and minimum diameters of the inferior vena cava with patients with acute kidney injury.
Day 1 of ICU admission
Percent Collapse of the Inferior Vena Cava in Patients With Acute Kidney Injury
The investigators will measure the maximum and minimum diameters of the inferior vena cava with patients with acute kidney injury and calculate the percent change between the maximum and minimum diameters.
Day 1 of ICU admission
Eligibility Criteria
Subjects ages 18-89 years with AKI (creatinine of 1.7mg/100ml or higher for less than 24 hours from baseline creatinine ≤1.2 or with unknown baseline creatinine). Standard of care treatment will not be different for patients taking part in this study. Participants will have bedside ultrasounds on days 0, 1, and 3, and baseline and follow-up data will be collected from medical records.
You may qualify if:
- Creatinine of 1.7 mg/100ml or higher for less than 24 hours from baseline creatinine ≤1.2 or with unknown baseline creatinine
- Age range: 18-89 years
- Age range ≥ 18
You may not qualify if:
- \. Only chronic renal disease will exclude a patient from our study regardless of past medical history and medications they are taking. (For the purposes of this study, any patient with creatinine higher than 1.2 mg /100ml for more than 24 hours will be identified as having chronic renal disease.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Tech Univrsity Health Science Center
Lubbock, Texas, 79430, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This study is straightforward and involves measurements of the inferior vena cava. The study population was heterogeneous. Study measurements depend on the ability to identify the inferior vena cava with precision and make accurate measurements.
Results Point of Contact
- Title
- Dr Kenneth Nugent
- Organization
- Texas Tech university Health Sciences Center, Lubbock, TX
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth M Nugent, MD
Texas Tech University Health Sciences Center
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2014
First Posted
June 17, 2014
Study Start
February 1, 2014
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
June 23, 2016
Results First Posted
June 23, 2016
Record last verified: 2016-06